𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Langerhans’ cell histiocytosis of the spine: use of MRI in guiding biopsy

✍ Scribed by G. R. Kaplan; A. Saifuddin; J. A. S. Pringle; M. H. Noordeen; M. H. Mehta


Publisher
Springer
Year
1998
Tongue
English
Weight
228 KB
Volume
27
Category
Article
ISSN
0364-2348

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Use of indomethacin in Langerhans cell h
✍ Munn, Stephanie E.; Olliver, Lucy; Broadbent, Valerie; Pritchard, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie

THE PRESENCE OF CYTOKINES IN LANGERHANS'
✍ DE GRAAF, JAN H.; TAMMINGA, RIENK Y. J.; DAM-MEIRING, ANKE; KAMPS, WILLEM A.; TI 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

Langerhans' cell histiocytosis (LCH) is characterized by an accumulation and/or proliferation of cells with a Langerhans' cell (LC) phenotype. The aetiology and pathogenesis of LCH are unknown; it is suggested that LCH is caused by an immunological dysregulation. Production of cytokines is a central

Radiation therapy in the management of l
✍ Selch, Michael T. ;Parker, Robert G. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

## Abstract Twenty‐two patients with Langerhans cell histiocytosis (LCH) were managed in the UCLA Department of Radiation Oncology from 1974 to 1987. Their median age was 17 years (range 1–42 years) and median followup 4.5 years (range 1–13 years). Fourteen patients had disease localized to a bone